Hankang Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Hankang Capital is an investment firm.
Investor Profile
Hankang Capital has backed more than 9 startups, with 7 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Pharmaceutical, Biotechnology, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Series B (44%)
- Series C (22%)
- Series D (11%)
- Series A (11%)
- Angel (11%)
Country Focus
- China (78%)
- United States (22%)
Industry Focus
- Pharmaceutical
- Biotechnology
- Therapeutics
- Biopharma
- Health Care
- Medical
- Manufacturing
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
